Feedback

Relative change of LDL cholesterol after PCSK9 inhibitor therapy.

  • Michael Kühl (132789)
  • Christian Binner (6236801)
  • Joanna Jozwiak (6236804)
  • Julia Fischer (173836)
  • Jochen Hahn (6236807)
  • Alaeldin Addas (6236810)
  • Boris Dinov (6236813)
  • Jens Garbade (6236816)
  • Gerhard Hindricks (52344)
  • Michael Borger (5003072)
Open link
Publication date
January 2019
Icon DOI
10.1371/journal.pone.0210373.g001
Publisher
Public Library of Science (PLoS)

Abstract

Therapy with PCSK9 inhibitors resulted in an overall LDL cholesterol reduction of 40%. As can be seen, the LDL cholesterol levels of individual patients (X-axis) ranged between +26% and -66% when comparing LDL levels after PCSK9 inhibitor therapy to baseline.</p

Extracted data

We use cookies to provide a better user experience.
Data Protection